½ÃÀ庸°í¼­
»óǰÄÚµå
1652090

¼¼°èÀÇ ÀüÀÚ ¾à±¹ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¾÷°è ºÐ¼® : ÀǾàǰ À¯Çüº°, Á¦Ç° À¯Çüº°, °áÁ¦¹æ¹ýº°, Ç÷§Æûº°, Áö¿ªº° - ¿¹Ãø(2025-2034³â)

E-pharmacy Market Size, Share, Trends, Industry Analysis Report: By Drug Type, Product Type, Payment Method, Platform, and Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 128 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ ÀüÀÚ ¾à±¹ ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 5,298¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ Á¶»ç ¸®Æ÷Æ®´Â ÇöÀç ½ÃÀå ¿ªÇÐÀÇ »ó¼¼ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ °üÇÑ ºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

ÀüÀÚ ¾à±¹ ½ÃÀåÀº µðÁöÅÐ ±â¼úÀÇ º¸±Þ°ú ¼ÒºñÀÚ ÇൿÀÇ º¯È­·Î ÀÎÇØ ÃÖ±Ù ±Þ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚ ¾à±¹Àº 󹿾à, ÀϹÝÀǾàǰ, °Ç°­º¸Á¶½Äǰ, ÆÛ½º³ÎÄɾî Á¦Ç°À» ±¸¸ÅÇÒ ¼ö ÀÖ´Â ¿Â¶óÀÎ Ç÷§ÆûÀ» Á¦°øÇÏ¿© ¼ÒºñÀÚ¿¡°Ô Å« ÆíÀǸ¦ Á¦°øÇÕ´Ï´Ù. ÀüÀÚ ¾à±¹ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä´Â ¿Â¶óÀÎ ¼îÇο¡ ´ëÇÑ ¼±È£µµ Áõ°¡, ºñ´ë¸é °Å·¡ÀÇ Çʿ伺, °Ç°­ °ü·Ã Á¦Ç°ÀÇ °¡¿ë¼º È®´ë µî¿¡ ÈûÀÔ¾î ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¸¼ºÁúȯ Áõ°¡¿Í °í·ÉÈ­·Î ÀÎÇØ Á¢±Ù¼º ³ôÀº ÀÇ·á¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

µðÁöÅÐ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀÇÁ¸µµ Áõ°¡, ÀÎÅÍ³Ý º¸±Þ·ü Áõ°¡, ¹°·ù ¹× ¹è¼Û ¼­ºñ½ºÀÇ ¹ßÀüÀº ÀüÀÚ ¾à±¹ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ±âȸ´Â ¿Â¶óÀÎ Ç÷§ÆûÀ» ÅëÇØ ´õ ¸¹Àº ¼ÒºñÀÚÃþ, ƯÈ÷ ³óÃÌ Áö¿ª°ú ¼Ò¿ÜµÈ Áö¿ªÀÇ ¼ÒºñÀÚÃþ¿¡ µµ´ÞÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ¿ë È¿À²ÀûÀÌ°í °³ÀÎÈ­µÈ ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀüÀÚ ¾à±¹Àº ¿ø°Ý »ó´ã ¹× ÅÃ¹è ¿É¼Ç°ú °°Àº ºÎ°¡ °¡Ä¡ ¼­ºñ½º¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù.

ÀüÀÚ ¾à±¹ ½ÃÀå Àü¸ÁÀº ¿©ÀüÈ÷ ÁÁÀ¸¸ç, ÇâÈÄ ¼ö³â°£ °è¼Ó ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â¼ú Çõ½Å°ú ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ¹ßÀüÇÔ¿¡ µû¶ó ÀüÀÚ ¾à±¹ ½ÃÀåÀº ´õ¿í È®´ëµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ±âÁ¸ ±â¾÷°ú ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷¿¡°Ô ÀÌ ¿ªµ¿ÀûÀÎ ½ÃÀå¿¡ ÁøÀÔÇÒ ¼ö ÀÖ´Â Å« ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀüÀÚ ¾à±¹ ½ÃÀå : ºÐ¼® °³¿ä

ÀǾàǰ À¯Çüº°·Î »ìÆìº¸¸é, 2024³â¿¡´Â ó¹æÀü ¾øÀ̵µ ½±°Ô ±¸ÇÒ ¼ö ÀÖ°í, ¼¿ÇÁ ¸ÞµðÄÉÀ̼ǿ¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó OTC ÀǾàǰ ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ÆÛ½º³Î ±×·ç¹Ö¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í °í±Þ ½ºÅ²Äɾî Á¦Ç°ÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ºÅ²ÄÉ¾î ºÐ¾ß°¡ ¿¹Ãø ±â°£ Áß °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2024³â¿¡´Â ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇߴµ¥, ÀÌ´Â Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶óÀÇ Á¸Àç¿Í ÀüÀÚ ¾à±¹ Ç÷§ÆûÀÇ ³ôÀº äÅ÷ü¿¡ ±âÀÎÇÑ °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀüÀÚ ¾à±¹ ½ÃÀåÀº ÀÎÅÍ³Ý º¸±Þ·ü Áõ°¡, Áß»êÃþ Áõ°¡, µðÁöÅÐ ÀǷḦ ÃËÁøÇÏ´Â Á¤ºÎ Áö¿øÃ¥À¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷Àº Express Scripts Holding, Giant Eagle, The Walgreen Company, Kroger Co, CVS Health Corporation, DocMorris, PharmEasy, Wal-Mart Stores, OptumRx, Rowland Pharmacy, Lloyds Pharmacy Ltd (McKesson Corporation), 1mg, Netmeds, Apollo Pharmacy µîÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå °³¿ä

Á¦3Àå ºÐ¼® ¹æ¹ý

Á¦4Àå ÀüÀÚ ¾à±¹ ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ½º³À¼ô
  • ÀüÀÚ ¾à±¹ ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀΰú ±âȸ
      • Áõ´ëÇÏ´Â ¹æÀ§ºñ
      • ±¹°æ °æºñÀÇ Çʿ伺ÀÌ ³ô¾ÆÁø´Ù.
    • ¾ïÁ¦¿äÀΰú °úÁ¦
      • ³ôÀº °³¹ß ¹× ¿î¿µ ºñ¿ë
  • PESTLE ºÐ¼®
  • ÀüÀÚ ¾à±¹ ½ÃÀå µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ÀüÀÚ ¾à±¹ ½ÃÀå : ÀǾàǰ À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • ÀüÀÚ ¾à±¹ ½ÃÀå : ÀǾàǰ À¯Çüº°(2020-2034³â)
  • 󹿾à
    • ÀüÀÚ ¾à±¹ ½ÃÀå : 󹿾à(Áö¿ªº°(2020-2034³â))
  • OTC ÀǾàǰ(ÀϹÝÀǾàǰ)
    • ÀüÀÚ ¾à±¹ ½ÃÀå : OTC ÀǾàǰ(Áö¿ªº°(2020-2034³â))

Á¦6Àå ÀüÀÚ ¾à±¹ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • ÀüÀÚ ¾à±¹ ½ÃÀå : Á¦Ç° À¯Çüº°(2020-2034³â)
  • ½ºÅ²Äɾî
    • ÀüÀÚ ¾à±¹ ½ÃÀå : ½ºÅ²Äɾî(Áö¿ªº°(2020-2034³â))
  • Ä¡°ú
    • ÀüÀÚ ¾à±¹ ½ÃÀå : Ä¡°ú(Áö¿ªº°(2020-2034³â))
  • °¨±â¿Í ÀÎÇ÷翣ÀÚ
    • ÀüÀÚ ¾à±¹ ½ÃÀå : °¨±â¡¤ÀÎÇ÷翣ÀÚ(Áö¿ªº°(2020-2034³â))
  • ºñŸ¹Î
    • ÀüÀÚ ¾à±¹ ½ÃÀå : ºñŸ¹Î(Áö¿ªº°(2020-2034³â))
  • üÁß°¨·®
    • ÀüÀÚ ¾à±¹ ½ÃÀå : °¨·®(Áö¿ªº°(2020-2034³â))
  • ±âŸ À¯Çü Á¦Ç°
    • ÀüÀÚ ¾à±¹ ½ÃÀå : ±âŸ À¯Çü Á¦Ç°(Áö¿ªº°(2020-2034³â))

Á¦7Àå ÀüÀÚ ¾à±¹ ½ÃÀå : °áÁ¦¹æ¹ýº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • ÀüÀÚ ¾à±¹ ½ÃÀå : °áÁ¦¹æ¹ýº°(2020-2034³â)
  • ´ë±Ý »óȯ
    • ÀüÀÚ ¾à±¹ ½ÃÀå : ´ë±Ý »óȯ(Áö¿ªº°(2020-2034³â))
  • ¿Â¶óÀÎ °áÁ¦
    • ÀüÀÚ ¾à±¹ ½ÃÀå : ¿Â¶óÀÎ °áÁ¦(Áö¿ªº°(2020-2034³â))

Á¦8Àå ÀüÀÚ ¾à±¹ ½ÃÀå : Ç÷§Æûº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • ÀüÀÚ ¾à±¹ ½ÃÀå : Ç÷§Æûº°(2020-2034³â)
  • ¾Û ±â¹Ý
    • ÀüÀÚ ¾à±¹ ½ÃÀå : ¾Û ±â¹Ý(Áö¿ªº°(2020-2034³â))
  • À¥±â¹Ý
    • ÀüÀÚ ¾à±¹ ½ÃÀå : À¥±â¹Ý(Áö¿ªº°(2020-2034³â))

Á¦9Àå ¼¼°èÀÇ ÀüÀÚ ¾à±¹ ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä ºÐ¼® °á°ú
  • ¼­·Ð
    • ÀüÀÚ ¾à±¹ ½ÃÀå Æò°¡ : Áö¿ªº°(2020-2034³â)
  • ºÏ¹Ì
    • ºÏ¹Ì : ÀǾàǰ À¯Çüº°(2020-2034³â)
    • ºÏ¹Ì : Á¦Ç° À¯Çüº°(2020-2034³â)
    • ºÏ¹Ì : °áÁ¦¹æ¹ýº°(2020-2034³â)
    • ºÏ¹Ì : Ç÷§Æûº°(2020-2034³â)
    • ¹Ì±¹
      • ¹Ì±¹ : ¾àÁ¦ À¯Çüº°(2020-2034³â)
      • ¹Ì±¹ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ¹Ì±¹ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ¹Ì±¹ : Ç÷§Æûº°(2020-2034³â)
    • ij³ª´Ù
      • ij³ª´Ù : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ij³ª´Ù : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ij³ª´Ù : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ij³ª´Ù : Ç÷§Æûº°(2020-2034³â)
  • À¯·´
    • À¯·´ : ÀǾàǰ À¯Çüº°(2020-2034³â)
    • À¯·´ : Á¦Ç° À¯Çüº°(2020-2034³â)
    • À¯·´ : °áÁ¦¹æ¹ýº°(2020-2034³â)
    • À¯·´ : Ç÷§Æûº°(2020-2034³â)
    • ¿µ±¹
      • ¿µ±¹ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ¿µ±¹ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ¿µ±¹ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ¿µ±¹ : Ç÷§Æûº°(2020-2034³â)
    • ÇÁ¶û½º
      • ÇÁ¶û½º : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ÇÁ¶û½º : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ÇÁ¶û½º : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ÇÁ¶û½º : Ç÷§Æûº°(2020-2034³â)
    • µ¶ÀÏ
      • µ¶ÀÏ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • µ¶ÀÏ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • µ¶ÀÏ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • µ¶ÀÏ : Ç÷§Æûº°(2020-2034³â)
    • ÀÌÅ»¸®¾Æ
      • ÀÌÅ»¸®¾Æ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ÀÌÅ»¸®¾Æ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ÀÌÅ»¸®¾Æ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ÀÌÅ»¸®¾Æ : Ç÷§Æûº°(2020-2034³â)
    • ½ºÆäÀÎ
      • ½ºÆäÀÎ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ½ºÆäÀÎ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ½ºÆäÀÎ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ½ºÆäÀÎ : Ç÷§Æûº°(2020-2034³â)
    • ³×´ú¶õµå
      • ³×´ú¶õµå : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ³×´ú¶õµå : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ³×´ú¶õµå : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ³×´ú¶õµå : Ç÷§Æûº°(2020-2034³â)
    • ·¯½Ã¾Æ
      • ·¯½Ã¾Æ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ·¯½Ã¾Æ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ·¯½Ã¾Æ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ·¯½Ã¾Æ : Ç÷§Æûº°(2020-2034³â)
    • ±âŸ À¯·´
      • ±âŸ À¯·´ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ±âŸ À¯·´ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ±âŸ À¯·´ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ±âŸ À¯·´ : Ç÷§Æûº°(2020-2034³â)
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀǾàǰ À¯Çüº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦Ç° À¯Çüº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : °áÁ¦¹æ¹ýº°(2020-2034³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : Ç÷§Æûº°(2020-2034³â)
    • Áß±¹
      • Áß±¹ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • Áß±¹ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • Áß±¹ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • Áß±¹ : Ç÷§Æûº°(2020-2034³â)
    • Àεµ
      • Àεµ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • Àεµ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • Àεµ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • Àεµ : Ç÷§Æûº°(2020-2034³â)
    • ¸»·¹À̽þÆ
      • ¸»·¹ÀÌ½Ã¾Æ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ¸»·¹ÀÌ½Ã¾Æ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ¸»·¹ÀÌ½Ã¾Æ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ¸»·¹ÀÌ½Ã¾Æ : Ç÷§Æûº°(2020-2034³â)
    • ÀϺ»
      • ÀϺ» : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ÀϺ» : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ÀϺ» : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ÀϺ» : Ç÷§Æûº°(2020-2034³â)
    • Àεµ³×½Ã¾Æ
      • Àεµ³×½Ã¾Æ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • Àεµ³×½Ã¾Æ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • Àεµ³×½Ã¾Æ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • Àεµ³×½Ã¾Æ : Ç÷§Æûº°(2020-2034³â)
    • Çѱ¹
      • Çѱ¹ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • Çѱ¹ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • Çѱ¹ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • Çѱ¹ : Ç÷§Æûº°(2020-2034³â)
    • È£ÁÖ
      • È£ÁÖ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • È£ÁÖ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • È£ÁÖ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • È£ÁÖ : Ç÷§Æûº°(2020-2034³â)
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç : Ç÷§Æûº°(2020-2034³â)
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀǾàǰ À¯Çüº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Ç° À¯Çüº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °áÁ¦¹æ¹ýº°(2020-2034³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ç÷§Æûº°(2020-2034³â)
    • »ç¿ìµð¾Æ¶óºñ¾Æ
      • »ç¿ìµð¾Æ¶óºñ¾Æ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • »ç¿ìµð¾Æ¶óºñ¾Æ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • »ç¿ìµð¾Æ¶óºñ¾Æ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • »ç¿ìµð¾Æ¶óºñ¾Æ : Ç÷§Æûº°(2020-2034³â)
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
      • UAE : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • UAE : Á¦Ç° À¯Çüº°(2020-2034³â)
      • UAE : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • UAE : Ç÷§Æûº°(2020-2034³â)
    • À̽º¶ó¿¤
      • À̽º¶ó¿¤ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • À̽º¶ó¿¤ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • À̽º¶ó¿¤ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • À̽º¶ó¿¤ : Ç÷§Æûº°(2020-2034³â)
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ : Ç÷§Æûº°(2020-2034³â)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Ç÷§Æûº°(2020-2034³â)
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀǾàǰ À¯Çüº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç° À¯Çüº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : °áÁ¦¹æ¹ýº°(2020-2034³â)
    • ¶óƾ¾Æ¸Þ¸®Ä« : Ç÷§Æûº°(2020-2034³â)
    • ¸ß½ÃÄÚ
      • ¸ß½ÃÄÚ : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ¸ß½ÃÄÚ : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ¸ß½ÃÄÚ : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ¸ß½ÃÄÚ : Ç÷§Æûº°(2020-2034³â)
    • ºê¶óÁú
      • ºê¶óÁú : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ºê¶óÁú : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ºê¶óÁú : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ºê¶óÁú : Ç÷§Æûº°(2020-2034³â)
    • ¾Æ¸£ÇîÆ¼³ª
      • ¾Æ¸£ÇîÆ¼³ª : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ¾Æ¸£ÇîÆ¼³ª : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ¾Æ¸£ÇîÆ¼³ª : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ¾Æ¸£ÇîÆ¼³ª : Ç÷§Æûº°(2020-2034³â)
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« : ÀǾàǰ À¯Çüº°(2020-2034³â)
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç° À¯Çüº°(2020-2034³â)
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« : °áÁ¦¹æ¹ýº°(2020-2034³â)
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« : Ç÷§Æûº°(2020-2034³â)

Á¦10Àå °æÀï ±¸µµ

  • »ç¾÷ È®´ë¡¤±â¾÷ Àμö ºÐ¼®
    • »ç¾÷ È®´ë
    • ±â¾÷ Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦11Àå ±â¾÷ °³¿ä

  • Express Scripts Holding
  • Giant Eagle
  • The Walgreen Company
  • Kroger Co
  • CVS Health Corporation
  • DocMorris
  • PharmEasy
  • Wal-Mart Stores
  • OptumRx
  • Rowland Pharmacy
  • Lloyds Pharmacy Ltd(McKesson Corporation)
  • 1mg
  • Netmeds
  • Apollo Pharmacy
KSA 25.03.13

The global e-pharmacy market size is expected to reach USD 529.87 billion by 2034, according to a new study by Polaris Market Research. The report "E-pharmacy Market Share, Size, Trends, Industry Analysis Report: By Drug Type (Prescription Drugs, and OTC Drugs), Product Type, Payment Method, Platform, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The e-pharmacy market has witnessed rapid growth in recent years, driven by the widespread adoption of digital technologies and changing consumer behavior. E-pharmacies provide an online platform for purchasing prescription medications, over-the-counter drugs, health supplements, and personal care products, offering significant convenience to consumers. The demand for e-pharmacy services has surged, fueled by the growing preference for online shopping, the need for contactless transactions, and the expanding availability of health-related products. Additionally, the rise of chronic diseases and the aging population have heightened the demand for accessible healthcare services.

The increasing reliance on digital healthcare solutions, enhanced internet penetration, and advancements in logistics and delivery services are propelling the e-pharmacy market expansion. The market opportunity lies in the potential to reach a broader consumer base, especially in rural and underserved areas, through online platforms. Moreover, the growing focus on cost-effective and personalized healthcare has prompted e-pharmacies to introduce value-added services such as teleconsultations and home delivery options.

The market outlook for e-pharmacies remains positive, with projections indicating continued growth in the coming years. As technological innovations and regulatory frameworks evolve, the e-pharmacy market is expected to expand further, offering substantial opportunities for existing players and new entrants to tap into this dynamic market.

Key Highlights of E-pharmacy Market Report

Based on drug type, in 2024, the OTC drugs segment accounted for the largest market share in the market due to its widespread availability without prescriptions and increasing consumer preference for self-medication.

The skin care segment, based on product type, is expected to witness the fastest growth during the forecast period due to the rising awareness of personal grooming and the increasing adoption of advanced skin care products.

In 2024, North America accounted for the largest market share due to the presence of well-established healthcare infrastructure and a high adoption rate of e-pharmacy platforms.

The Asia Pacific e-pharmacy market is expected to witness the fastest growth during the forecast period due to increasing internet penetration, growing middle-class income, and supportive government initiatives promoting digital healthcare.

A few of the key market players are Express Scripts Holding, Giant Eagle, The Walgreen Company, Kroger Co, CVS Health Corporation, DocMorris, PharmEasy, Wal-Mart Stores, OptumRx, Rowland Pharmacy, Lloyds Pharmacy Ltd (McKesson Corporation), 1mg, Netmeds, and Apollo Pharmacy.

Polaris Market Research has segmented the e-pharmacy market research report on the basis of drug type, product type, payment method, platform, and region:

By Drug Type Outlook (Revenue - USD Billion, 2020-2034)

  • Prescription Drug
  • OTC Drug

By Product Type Outlook (Revenue - USD Billion, 2020-2034)

  • Skin Care
  • Dental
  • Cold and Flu
  • Vitamins
  • Weight Loss
  • Other Product Types

By Payment Method Outlook (Revenue - USD Billion, 2020-2034)

  • Cash On Delivery
  • Online Payment

By Platform Outlook (Revenue - USD Billion, 2020-2034)

  • App Based
  • Web Based

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. E-pharmacy Market Insights

  • 4.1. E-pharmacy Market - Market Snapshot
  • 4.2. E-pharmacy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Defense Expenditures
      • 4.2.1.2. Rising Border Security Needs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Development and Operational Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. E-pharmacy Market Power Rating Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. E-pharmacy Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
  • 5.3. Prescription Drug
    • 5.3.1. E-pharmacy Market, by Prescription Drug, by Region, 2020-2034 (USD Billion)
  • 5.4. OTC Drug
    • 5.4.1. E-pharmacy Market, by OTC Drug, by Region, 2020-2034 (USD Billion)

6. E-pharmacy Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
  • 6.3. Skin Care
    • 6.3.1. E-pharmacy Market, by Skin Care, by Region, 2020-2034 (USD Billion)
  • 6.4. Dental
    • 6.4.1. E-pharmacy Market, by Dental, by Region, 2020-2034 (USD Billion)
  • 6.5. Cold and Flu
    • 6.5.1. E-pharmacy Market, by Cold and Flu, by Region, 2020-2034 (USD Billion)
  • 6.6. Vitamins
    • 6.6.1. E-pharmacy Market, by Vitamins, by Region, 2020-2034 (USD Billion)
  • 6.7. Weight Loss
    • 6.7.1. E-pharmacy Market, by Weight Loss, by Region, 2020-2034 (USD Billion)
  • 6.8. Other Product Types
    • 6.8.1. E-pharmacy Market, by Other Product Types, by Region, 2020-2034 (USD Billion)

7. E-pharmacy Market, by Payment Method

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
  • 7.3. Cash On Delivery
    • 7.3.1. E-pharmacy Market, by Cash On Delivery, by Region, 2020-2034 (USD Billion)
  • 7.4. Online Payment
    • 7.4.1. E-pharmacy Market, by Online Payment, by Region, 2020-2034 (USD Billion)

8. E-pharmacy Market, by Platform

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
  • 8.3. App Based
    • 8.3.1. E-pharmacy Market, by App Based, by Region, 2020-2034 (USD Billion)
  • 8.4. Web Based
    • 8.4.1. E-pharmacy Market, by Web Based, by Region, 2020-2034 (USD Billion)

9. E-pharmacy Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. E-pharmacy Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. E-pharmacy Market - North America
    • 9.3.1. North America: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
    • 9.3.3. North America: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
    • 9.3.4. North America: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.3.5. E-pharmacy Market - US
      • 9.3.5.1. US: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.3.5.2. US: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.3.5.3. US: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.3.5.4. US: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.3.6. E-pharmacy Market - Canada
      • 9.3.6.1. Canada: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
  • 9.4. E-pharmacy Market - Europe
    • 9.4.1. Europe: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
    • 9.4.3. Europe: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
    • 9.4.4. Europe: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.4.5. E-pharmacy Market - UK
      • 9.4.5.1. UK: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.4.6. E-pharmacy Market - France
      • 9.4.6.1. France: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.6.3. France: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.4.6.4. France: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.4.7. E-pharmacy Market - Germany
      • 9.4.7.1. Germany: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.4.8. E-pharmacy Market - Italy
      • 9.4.8.1. Italy: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.4.9. E-pharmacy Market - Spain
      • 9.4.9.1. Spain: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.4.10. E-pharmacy Market - Netherlands
      • 9.4.10.1. Netherlands: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.4.11. E-pharmacy Market - Russia
      • 9.4.11.1. Russia: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.4.12. E-pharmacy Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
  • 9.5. E-pharmacy Market - Asia Pacific
    • 9.5.1. Asia Pacific: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.5.5. E-pharmacy Market - China
      • 9.5.5.1. China: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.5.3. China: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.5.5.4. China: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.5.6. E-pharmacy Market - India
      • 9.5.6.1. India: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.6.3. India: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.5.6.4. India: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.5.7. E-pharmacy Market - Malaysia
      • 9.5.7.1. Malaysia: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.5.8. E-pharmacy Market - Japan
      • 9.5.8.1. Japan: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.5.9. E-pharmacy Market - Indonesia
      • 9.5.9.1. Indonesia: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.5.10. E-pharmacy Market - South Korea
      • 9.5.10.1. South Korea: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.5.11. E-pharmacy Market - Australia
      • 9.5.11.1. Australia: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.5.12. E-pharmacy Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
  • 9.6. E-pharmacy Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.6.5. E-pharmacy Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.6.6. E-pharmacy Market - UAE
      • 9.6.6.1. UAE: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.6.7. E-pharmacy Market - Israel
      • 9.6.7.1. Israel: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.6.8. E-pharmacy Market - South Africa
      • 9.6.8.1. South Africa: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.6.9. E-pharmacy Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
  • 9.7. E-pharmacy Market - Latin America
    • 9.7.1. Latin America: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.7.5. E-pharmacy Market - Mexico
      • 9.7.5.1. Mexico: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.7.6. E-pharmacy Market - Brazil
      • 9.7.6.1. Brazil: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.7.7. E-pharmacy Market - Argentina
      • 9.7.7.1. Argentina: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)
    • 9.7.8. E-pharmacy Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: E-pharmacy Market, by Drug Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: E-pharmacy Market, by Product Type, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: E-pharmacy Market, by Payment Method, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: E-pharmacy Market, by Platform, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Express Scripts Holding
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Giant Eagle
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. The Walgreen Company
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Kroger Co
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. CVS Health Corporation
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. DocMorris
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. PharmEasy
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Wal-Mart Stores
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. OptumRx
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Rowland Pharmacy
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Lloyds Pharmacy Ltd (McKesson Corporation)
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. 1mg
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Netmeds
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Apollo Pharmacy
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦